meta-chlorphenylbiguanide   Click here for help

GtoPdb Ligand ID: 2287

Abbreviated name: mCPBG
Synonyms: 1-(3-chlorophenyl)biguanide | 3-chlorophenyl-biguanide | m-chlorophenylbiguanide
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 2
Topological polar surface area 102.78
Molecular weight 211.06
XLogP 0.31
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Clc1cccc(c1)N=C(N=C(N)N)N
Isomeric SMILES Clc1cccc(c1)N=C(N=C(N)N)N
InChI InChI=1S/C8H10ClN5/c9-5-2-1-3-6(4-5)13-8(12)14-7(10)11/h1-4H,(H6,10,11,12,13,14)
1. Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ, Blackburn TP. (1995)
Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
Mol Pharmacol, 48 (6): 1054-62. [PMID:8848005]
2. Brady CA, Stanford IM, Ali I, Lin L, Williams JM, Dubin AE, Hope AG, Barnes NM. (2001)
Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors.
Neuropharmacology, 41 (2): 282-4. [PMID:11489465]
3. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. (1999)
The 5-HT3B subunit is a major determinant of serotonin-receptor function.
Nature, 397 (6717): 359-63. [PMID:9950429]
4. Hope AG, Peters JA, Brown AM, Lambert JJ, Blackburn TP. (1996)
Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells.
Br J Pharmacol, 118 (5): 1237-45. [PMID:8818349]
5. Ito H, Kiso T, Miyata K, Kamato T, Yuki H, Akuzawa S, Nagakura Y, Yamano M, Suzuki M, Naitoh Y et al.. (2000)
Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.
Eur J Pharmacol, 409 (2): 195-201. [PMID:11104834]
6. Lankiewicz S, Lobitz N, Wetzel CH, Rupprecht R, Gisselmann G, Hatt H. (1998)
Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
Mol Pharmacol, 53 (2): 202-12. [PMID:9463477]
7. Mair ID, Lambert JJ, Yang J, Dempster J, Peters JA. (1998)
Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
Br J Pharmacol, 124 (8): 1667-74. [PMID:9756382]
8. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S. (1995)
Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
Mol Pharmacol, 48 (3): 407-16. [PMID:7565620]
9. Mochizuki S, Miyake A, Furuichi K. (1999)
Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
Eur J Pharmacol, 369 (1): 125-32. [PMID:10204690]
10. Niemeyer MI, Lummis SC. (1998)
Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Br J Pharmacol, 123 (4): 661-6. [PMID:9517385]